Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma
Medical Sciences · 13.04.2026 · 14 (2) · 195
DOI: 10.3390/medsci14020195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 13.04.2026. Verfasst von Antonio Luigi Manai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Cagliari, 09042 Monserrato, CA, Italy. Hauptthemen laut MEDLINE: alpha-Synuclein, Brain. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In Parkinson’s disease (PD), changes in the brain begin before clinical symptoms. We have previously shown that VGF precursor levels were reduced in a presymptomatic PD animal model.
Objectives
In the present study, we investigated whether two VGF precursor-derived products, namely NAPP-129 protein and TLQP-62 peptide, also exhibit alterations using the same PD animal model.
Methods
Specifically, rats were unilaterally injected in the substantia nigra with a viral vector overexpressing green fluorescent protein (N = 12) or α-synuclein (N = 13), the latter resulting in mild dopaminergic alterations without overt motor deficits.
Results
NAPP-129 and TLQP-62 were investigated in the substantia nigra, striatum, and plasma by Western blotting or immunoassays using specific antibodies against NAPP and TLQP sequences, alongside other NERP-1- and AQEE-related products. Plasma samples of a Huntington’s disease mouse model were also analyzed. We found reductions in NAPP-129 and TLQP-62 levels in the substantia nigra along with a decrease in NAPP- and TLQP-like plasma immunoreactivity in α-synuclein-overexpressed rats, while the striatum was not affected. NERP-1- and AQEE-related products were not altered. No changes were found in the Huntington’s disease model.
Conclusions
These findings indicate that NAPP-129 and TLQP-62 may enhance the sensitivity and specificity of biomarker-based strategies for PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of Cagliari, 09042 Monserrato, CA, Italy.
- National Research Council-Institute of Translational Pharmacology, 09050 Pula, CA, Italy.
- School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK.
ORCID-Profile: Antonio Luigi Manai, Barbara Noli, Aqsa Anjum, Maria Antonietta Casu, Marie-Christine Pardon, Cristina Cocco
Zitieren
APA
Manai, A. L., Noli, B., Anjum, A., Manca, E., Casu, M. A., Pardon, M. C., & Cocco, C. (2026). Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma. Medical Sciences, 14(2), 195. https://doi.org/10.3390/medsci14020195
Vancouver
Manai AL, Noli B, Anjum A, Manca E, Casu MA, Pardon MC, et al. Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma. Medical Sciences. 2026;14(2):195. doi:10.3390/medsci14020195
BibTeX
@article{Manai2026,
author = {Manai, Antonio Luigi and Noli, Barbara and Anjum, Aqsa and Manca, Elias and Casu, Maria Antonietta and Pardon, Marie-Christine and Cocco, Cristina},
title = {Effect of α-Synuclein Overexpression on NAPP-129 and TLQP-62 in Rat Brain and Plasma},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {195},
doi = {10.3390/medsci14020195}
}
EUVIMED